Feb 22 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* Likely to restate results, period in question is late 2014 and early 2015 -
wsj
* Board has been meeting in recent days, and a decision on the potential
revision has not yet been finalized - wsj
* Source text - http://on.wsj.com/21lWKxM
* Further company coverage VRX.TO